Target intelligence / Profile preview

Selective T-cell deletion

Molecular classification
Other (Biological process; not a molecule or protein)
01

Overview

Selective T-cell deletion refers to the physiological removal of self-reactive or undesirable T-cell clones from the immune repertoire. This typically occurs in the thymus (central tolerance) via clonal deletion—where T cells with high-affinity recognition of self-antigens presented by thymic antigen-presenting cells undergo apoptosis—and can also occur in peripheral tissues (peripheral tolerance)[1][3][7]. This process is crucial for preventing autoimmunity and promoting immune homeostasis. While not a therapeutic target itself, the mechanisms underlying selective T-cell deletion are researched for interventions in autoimmunity, transplant tolerance, and immuno-oncology[1][2][5].

Other names
Clonal deletionT-cell clonal deletionNegative selection (T-cell)T-cell deletion
02

Mechanism of action

Induction of T-cell apoptosis via high-affinity self-antigen recognition on MHC complexes, leading to clonal deletion[1][3][5][7]

03

Biological functions

Immune toleranceNegative selectionApoptosis of autoreactive T cellsClonal deletionPeripheral tolerance
04

Disease associations

AutoimmunityCancer immunotherapyImmune toleranceTransplantation tolerance
05

Safety considerations

Excessive T-cell deletion can cause immunodeficiencyInsufficient deletion leads to autoimmunity
06

Interacting drugs

Antigen administration

2 more in the full profile.

07

Biomarkers

Peripheral T-cell reductionThymic apoptosis

Beyond the preview

Go deeper on Selective T-cell deletion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Selective T-cell deletion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call